ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1408

Impact of Disease Activity on Functional Impairment in Patients with Spondyloarthritis Is Different According to the Degree of Radiographic Progression: Result from SNUH-AS Cohort

Ji In Jung1, Ju Yeon Kim2, Jin Kyun Park3, Eun Young Lee3, Eun Bong Lee2 and Jun Won Park2, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 2Seoul National University Hospital, Seoul, South Korea, 3Seoul National University College of Medicine, Seoul, South Korea

Meeting: ACR Convergence 2023

Keywords: Ankylosing spondylitis (AS), Disease Activity, functional status

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1383–1411) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Imaging & AS

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Although previous studies suggested that physical functioning is largely driven by disease activity in patients with spondyloarthritis (SpA), its relationship to radiographic progression has not been thoroughly investigated. The aim of this study was to investigate whether the effect of disease activity on physical function varies according to the radiographic progression in SpA patients.

Methods: This cross-sectional study used baseline data from the patients in a single-center, prospective cohort of SpA. Disease activity was assessed through Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Ankylosing Spondylitis Disease Activity Score (ASDAS). Physical function was measured using Bath Ankylosing Spondylitis Functional Index (BASFI) and functional impairment of the patients was defined as BASFI ≥4. Radiographic progression of SpA was assessed using modified Stoke Ankylosing Spondylitis Spine Score (mSASSS). Clinical factors related to functional impairment of the patient were investigated using logistic regression analysis.

Results: A total of 221 patients were analyzed. Mean (SD) age at baseline was 43.4 (14.1) yeas and 176 (79.6%) were male. Mean (SD) disease duration of the included patients was 7.5 (9.5) years. Remission or low disease activity (LDA, ASDAS-CRP < 2.1) was achieved in 149 (67.4%) patients. Mean (SD) mSASSS was 19.5 (20.6) and 96 (43.4%) patients had at least one syndesmophyte on baseline spinal radiographs.

At the baseline, functional impairment was present in 41 (18.6%) patients. Univariable analysis showed that older age at diagnosis, shorter disease duration based on two years, and higher ASDAS-CRP were associated with functional impairment. Although the effect of ASDAS-CRP on the outcome was consistent in the multivariable analysis (adjusted OR 2.46 [95% CI 1.70-3.58]), it was significantly different according to the severity of radiographic progression (P value for interaction = 0.001). In the absence of bridging syndesmophyte, increase in ASDAS-CRP was associated with more frequent functional impairment (adjusted OR 5.12 [2.61-10.05]). By contrast, in the subgroup of patients with bridging syndesmophyte, ASDAS-CRP did not increase the likelihood for functional impairment (adjusted OR 1.14 [0.70-1.86]). In fact, in the subgroup without bridging syndesmophyte, no patient with LDA showed a functional impairment. However, in advanced patients with bridging syndesmophyte, the rate of functional impairment was 23.8% despite achieving LDA. (Figure 1)

Conclusion: In the presence of advanced radiographic progression, low disease activity was not significantly associated with less functional impairment in patients with SpA, which suggests that early diagnosis and optimal treatment are critical for better physical function.

Supporting image 1


Disclosures: J. Jung: None; J. Kim: None; J. Park: None; E. Lee: None; E. Lee: Pfizer, 2; J. Park: None.

To cite this abstract in AMA style:

Jung J, Kim J, Park J, Lee E, Lee E, Park J. Impact of Disease Activity on Functional Impairment in Patients with Spondyloarthritis Is Different According to the Degree of Radiographic Progression: Result from SNUH-AS Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/impact-of-disease-activity-on-functional-impairment-in-patients-with-spondyloarthritis-is-different-according-to-the-degree-of-radiographic-progression-result-from-snuh-as-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-disease-activity-on-functional-impairment-in-patients-with-spondyloarthritis-is-different-according-to-the-degree-of-radiographic-progression-result-from-snuh-as-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology